NF-KB transcriptional regulation in the BACE1 promoter affects the amyloidogenic process in AD brains by stimulating astrocytes and repressing neuronal cells and non-activated astrocytes, and the NF-KB signaling activation plays a critical role in inflammatory responses, a key characteristic in AD development (39). This evidence concerns the gene NFKB1 and Alzheimer disease.